CEL383

N/A

Report date: 2023/06/14 20:00:35

Base Information

Drug NameCEL383
Drug Alias NameCEL-383
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTriggering receptor expressed on myeloid cells 1 inhibitors
TargetsTriggering receptor expressed on myeloid cells 1
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCelsius Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCelsius Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A